Bloomberg Markets Wrap 12/10: Stocks Drop Ahead of Fed Decision

The video discusses the market's view on inflation, highlighting the expected CPI numbers and bond yield trends. It then shifts focus to Sanofi's stock performance, driven by a strategic pivot towards oncology and rare diseases. Lastly, it analyzes Toll Brothers' stock, affected by disappointing guidance and challenges in the California market.

What is the market's expectation for the headline inflation rate in the upcoming CPI report?

• 2%

• 3%

• 1.5%

• 2.5%

What strategic change did Sanofi announce that led to a rise in its stock price?

• Focus on oncology and rare diseases

• Increase in R&D spending on cardio

• Expansion into diabetes research

• Partnership with a tech company

Who is the new CEO of Sanofi, and what is his background?

• Emily Clark from Roche

• Paul Hudson from Novartis

• Michael Brown from Merck

• John Smith from Pfizer

What was the main reason for the decline in Toll Brothers' stock?

• New government regulations

• Disappointing first-quarter guidance

• Rising construction costs

• Increased competition

Which market is particularly challenging for Toll Brothers, affecting their profitability?

• New York

• Texas

• California

• Florida